Division of Neurosurgery, Department of Surgery, Toronto Western Hospital, University of Toronto, University Health Network, Toronto, Ontario, Canada.
Neurosurgery. 2010 Sep;67(3):646-51; discussion 651. doi: 10.1227/01.NEU.0000375506.18902.3E.
Tremor is an important cause of disability in patients with multiple sclerosis (MS). Deep brain stimulation (DBS) in the ventral intermediate nucleus (VIM) of the thalamus is said to be beneficial for MS tremor.
To assess the long-term efficacy of VIM DBS for MS disabling tumor.
We treated 10 patients (4 men and 6 women) with advanced MS-related medication-resistant tremor with DBS at the VIM thalamic nucleus. DBS was unilateral in 9 patients and bilateral in 1 patient in 2 stages. Contralateral arm tremor was assessed with the Fahn-Tolosa-Marin tremor rating scale.
At 1 year, 5 of 10 patients (5 of 11 hemispheres) had a reduction in tremor scores with stimulation compared with baseline; in 3 patients, the reduction was > 50%. After 36 months, 3 patients continued benefiting from stimulation, 2 having > 50% improvement. Of the 6 symptomatic sides that did not benefit at 1 year, 3 failed to have even initial benefit, and 3 had a transient improvement lasting < 1 year. One patient stopped using stimulation because of a lack of improvement at 5 months after surgery and was lost to follow-up.
Approximately one-half of the patients derived some benefit from VIM DBS 1 year after surgery, but this benefit reached a > 50% reduction in only 30% of the patients. This level of improvement may be related to the variability of the demyelinating lesions and the superimposition of ataxia in the MS patients. Developing better treatments for MS tremor continues to be a challenge.
震颤是多发性硬化症(MS)患者致残的重要原因。丘脑腹中间核(VIM)的深部脑刺激(DBS)据称对 MS 震颤有益。
评估 VIM DBS 治疗 MS 致残性震颤的长期疗效。
我们用 DBS 治疗了 10 例(4 男 6 女)进展期 MS 相关药物难治性震颤患者,9 例为单侧,1 例分 2 期为双侧。用 Fahn-Tolosa-Marin 震颤评定量表评估对侧上肢震颤。
1 年后,10 例患者中有 5 例(11 个半脑中有 5 个)震颤评分在刺激时比基线降低;3 例降低>50%。36 个月后,3 例继续受益于刺激,2 例改善>50%。在 1 年时未受益的 6 个症状侧中,3 个最初也未受益,3 个仅有短暂改善(<1 年)。1 例患者因术后 5 个月无改善而停止使用刺激,失访。
大约一半的患者在手术后 1 年时从 VIM DBS 中获得了一些益处,但只有 30%的患者达到了>50%的缓解。这种改善程度可能与脱髓鞘病变的变异性以及 MS 患者的共济失调叠加有关。开发治疗 MS 震颤的更好方法仍然是一个挑战。